ANPLAG Side Effects

5759024-4 | Hypoglycaemia
on May 27, 2008 Female patient from KOREA, REPUBLIC OF , weighting 151.0 lb, was diagnosed with hypertension, diabetes mellitus and was treated with Anplag (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Anplag dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), OLDECA (View Oldeca Review and Oldeca Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GINEXIN F (View Ginexin-f Review and Ginexin-f Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

5736205-7 | Hypoglycaemia
Patient was taking Anplag (View Usage). Patient had the following side effects: hypoglycaemia on May 06, 2008 from KOREA, REPUBLIC OF Additional patient health information: Female patient , weighting 151.0 lb, was diagnosed with hypertension, diabetes mellitus and. Anplag dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), OLDECA (View Oldeca Review and Oldeca Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GINEXIN F (View Ginexin-f Review and Ginexin-f Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

5612353-7 | Hypoglycaemia
Adverse event was reported on Jan 30, 2008 by a Female patient taking Anplag (View Usage) (Dosage: ) was diagnosed with hypertension, diabetes mellitus and. Location: KOREA, REPUBLIC OF , weighting 151.0 lb, After Anplag was administered, patient had the following side effects: hypoglycaemia. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), OLDECA (View Oldeca Review and Oldeca Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GINEXIN F (View Ginexin-f Review and Ginexin-f Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

5166690-3 | Acute Pulmonary Oedema, Anorexia, Asthenia, Blood Creatinine Increased, Blood Gases Abnormal, Blood Lactate Dehydrogenase Increased, Blood Pressure Increased, Blood Urea Increased, Body Temperature Increased
on Sep 13, 2006 Female patient from JAPAN , 55 years of age, weighting 79.37 lb, was diagnosed with raynaud's phenomenon, biliary cirrhosis primary, joint destruction, prophylaxis against gastrointestinal ulcer, interstitial lung disease and was treated with Anplag (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, anorexia, asthenia, blood creatinine increased, blood gases abnormal, blood lactate dehydrogenase increased, blood pressure increased, blood urea increased, body temperature increased. Anplag dosage: 300 Mg/d. During the same period patient was treated with PRORENAL (10 Ug/d) (View Prorenal Review and Prorenal Label ), URSO (300 Mg/d) (View Urso Review and Urso Label ), PYDOXAL (20 Mg/d) (View Pydoxal Review and Pydoxal Label ), METALCAPTASE (300 Mg/d) (View Metalcaptase Review and Metalcaptase Label ), ALTAT (150 Mg/d) (View Altat Review and Altat Label ), LIPLE (1 Df, Qd) (View Liple Review and Liple Label ), PALUX (1 Df, Qd) (View Palux Review and Palux Label ), NEORAL (150 Mg/d) (View Neoral Review and Neoral Label ). Patient was hospitalized.


5154206-7 | Acute Pulmonary Oedema, Anorexia, Asthenia, Blood Creatinine Increased, Blood Gases Abnormal, Blood Lactate Dehydrogenase Increased, Blood Pressure Increased, Blood Urea Increased, Body Temperature Increased
on Sep 13, 2006 Female patient from JAPAN , 55 years of age, weighting 79.37 lb, was diagnosed with raynaud's phenomenon, biliary cirrhosis primary, joint destruction, prophylaxis against gastrointestinal ulcer, interstitial lung disease and was treated with Anplag (View Usage). Patient had the following side effects: acute pulmonary oedema, anorexia, asthenia, blood creatinine increased, blood gases abnormal, blood lactate dehydrogenase increased, blood pressure increased, blood urea increased, body temperature increased. Anplag dosage: 300 Mg/d. During the same period patient was treated with PRORENAL (10 Ug/d) (View Prorenal Review and Prorenal Label ), URSO (300 Mg/d) (View Urso Review and Urso Label ), PYDOXAL (20 Mg/d) (View Pydoxal Review and Pydoxal Label ), METALCAPTASE (300 Mg/d) (View Metalcaptase Review and Metalcaptase Label ), ALTAT (150 Mg/d) (View Altat Review and Altat Label ), LIPLE (1 Df, Qd) (View Liple Review and Liple Label ), PALUX (1 Df, Qd) (View Palux Review and Palux Label ), NEORAL (150 Mg/d) (View Neoral Review and Neoral Label ). Patient was hospitalized.

4628429-7 | Blood Potassium Increased, Cardiac Failure Acute, Chest Discomfort, Condition Aggravated, Dyspnoea, Renal Failure, Sinus Tachycardia
Patient was taking Anplag (View Usage). After Anplag was administered, patient had the following side effects: blood potassium increased, cardiac failure acute, chest discomfort, condition aggravated, dyspnoea, renal failure, sinus tachycardia on Dec 17, 2004 from Additional patient health information: Male patient , 84 years of age, was diagnosed with atherosclerosis obliterans, constipation (What is constipation?), hypertension and. Anplag dosage: . During the same period patient was treated with MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), EPADEL (View Epadel Review and Epadel Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ). Patient was hospitalized.

4606090-5 | Blood Potassium Increased, Cardiac Failure Acute, Chest Discomfort, Condition Aggravated, Dyspnoea, Renal Failure, Sinus Tachycardia
Adverse event was reported on Dec 17, 2004 by a Male patient taking Anplag (View Usage) (Dosage: ) was diagnosed with atherosclerosis obliterans, constipation (What is constipation?), hypertension and. Location: , 84 years of age, Patient experienced the following unwanted or unexpected effects: blood potassium increased, cardiac failure acute, chest discomfort, condition aggravated, dyspnoea, renal failure, sinus tachycardia. During the same period patient was treated with MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), EPADEL (View Epadel Review and Epadel Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ). Patient was hospitalized.